RE:RE:What next?Well said iscfa, anothet overlooked point is the BP Co. partner created the protocol and endpoints themselves in conjunction with Sirona. It was reported that all of the reported endpoints were achieved with the undeniable 100% of participants. Hence, the partner's paid study achieved the partners desired predetermined results. The 1067 proved itself again using their own evaluation criteria. A partnership deal with this Big Pharma company should result, if it doesn't then other questions need to be clearly answered.